4570 On Other Exchanges
Symbol
Exchange
4570 is not on other exchanges.

immuno-biological laboratori (4570) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for IMMUNO-BIOLOGICAL LABORATORI (4570)

Related News

No related news articles were found.

immuno-biological laboratori (4570) Related Businessweek News

No Related Businessweek News Found

immuno-biological laboratori (4570) Details

Immuno-Biological Laboratories Co., Ltd. engages in the research, development, manufacture, and supply of various immunological research reagents worldwide. It develops a range of antibodies and ELISA kits that are used research and development in the field of cancers, Alzheimer’s disease, and lifestyle diseases, such as diabetes. It also provides contract services to pharmaceutical firms and manufacturers of diagnostic products; and supplies antibodies for in-vitro diagnostic products, as well as licenses antibody drugs that are used in the treatment of cancer and other various diseases. In addition, the company offers LipoTEST support testing services for animal medical care; LipoSEARCH lipid profiling and analyzing services; customized biomarker testing services for life-style related diseases; and drug development and research support services. Further, it develops Neosilk-Human Collagen I from transgenic silkworms for various cosmetic products; and proteins for use in various drugs. Immuno-Biological Laboratories Co., Ltd. was founded in 1982 and is headquartered in Fujioka, Japan.

54 Employees
Last Reported Date: 06/30/16
Founded in 1982

immuno-biological laboratori (4570) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

immuno-biological laboratori (4570) Key Developments

Immuno-Biological Laboratories Co., Ltd. to Report Q1, 2017 Results on Aug 04, 2016

Immuno-Biological Laboratories Co., Ltd. announced that they will report Q1, 2017 results on Aug 04, 2016

Immuno-Biological Laboratories Co., Ltd., Annual General Meeting, Jun 29, 2016

Immuno-Biological Laboratories Co., Ltd., Annual General Meeting, Jun 29, 2016.

Immuno-Biological Laboratories Co., Ltd., 2016 Earnings Call, May 25, 2016

Immuno-Biological Laboratories Co., Ltd., 2016 Earnings Call, May 25, 2016

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4570 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4570.
View Industry Companies
 

Industry Analysis

4570

Industry Average

Valuation 4570 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 8.7x
Price/Book 1.9x
Price/Cash Flow NM Not Meaningful
TEV/Sales 5.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact IMMUNO-BIOLOGICAL LABORATORI, please visit www.ibl-japan.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.